Organisation Group: Department for Endocrinology and Radioimmunology
Academic Degree: Graduated in Molecular biology and physiology, MSc in Biology
Current position: Research Trainee
Education: Graduated in Molecular Biology and Physiology at the Faculty of Biology, University of Belgrade, Serbia (2014-2018)
MSc in Biology at the Faculty of Biology, University of Belgrade (2018-2019), master thesis: ‘’BRAF mutation activated long non-coding RNA expression as prognostic marker of papillary carcinoma of the thyroid gland.’’
Post academic studies: Faculty of Biology, University of Belgrade (2019-)
Stefana Stojanović is a member of a team working on the project named: “Molecular characterization of thyroid gland tumors: biological and clinical aspects”. The main goal of the project is better understanding the molecular pathogenesis of thyroid gland tumors, which could open great opportunities for the development of novel molecular-based approaches for the thyroid carcinoma diagnosis/prognosis and optimization of therapy in thyroid carcinomas patients.
Stefana Stojanović is working on the identification of novel diagnostic and prognostic molecular markers of thyroid gland tumors, where she mainly focuses on the presence of DNA mutations and changed RNA expressions during the thyroid carcinoma progression.
Membership in International and National Societies:
Serbian Biological Society
Serbian Society for Molecular Biology
Stojanović S, Šelemetjev S, Đorić I, Rončević J, Janković Miljuš J, Živaljević V, Išić Denčić T: Elevated BANCR expression levels have different effects on papillary thyroid carcinoma progression depending on the presence of the BRAFV600E mutation. Eur J Surg Oncol. 2020; 46 (10): 1835-1842./https://doi.org/10.1016/j.ejso.2020.05.027